{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:25:00Z","timestamp":1782483900683,"version":"3.54.5"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s12033-023-00934-5","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T19:01:40Z","timestamp":1698346900000},"page":"3117-3135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["THSD7A as a Promising Biomarker for Membranous Nephrosis"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3560-546X","authenticated-orcid":false,"given":"Shuiqing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"934_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.ajkd.2020.10.009","volume":"77","author":"L Alsharhan","year":"2021","unstructured":"Alsharhan, L., & Beck, L. H., Jr. (2021). Membranous Nephropathy: Core Curriculum 2021. American Journal of Kidney Diseases, 77, 440\u2013453. https:\/\/doi.org\/10.1053\/j.ajkd.2020.10.009","journal-title":"American Journal of Kidney Diseases"},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2165\/00002512-200724090-00002","volume":"24","author":"JK Deegens","year":"2007","unstructured":"Deegens, J. K., & Wetzels, J. F. (2007). Membranous nephropathy in the older adult: Epidemiology, diagnosis and management. Drugs and Aging, 24, 717\u2013732. https:\/\/doi.org\/10.2165\/00002512-200724090-00002","journal-title":"Drugs and Aging"},{"key":"934_CR3","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.930097","volume":"27","author":"L Wu","year":"2021","unstructured":"Wu, L., Lai, J., Ling, Y., Weng, Y., Zhou, S., Wu, S., Jiang, S., Ding, X., Jin, X., Yu, K., & Chen, Y. (2021). A review of the current practice of diagnosis and treatment of idiopathic membranous nephropathy in China. Medical Science Monitor, 27, e930097. https:\/\/doi.org\/10.12659\/MSM.930097","journal-title":"Medical Science Monitor"},{"key":"934_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000484717","volume":"4","author":"JH Hou","year":"2018","unstructured":"Hou, J. H., Zhu, H. X., Zhou, M. L., Le, W. B., Zeng, C. H., Liang, S. S., Xu, F., Liang, D. D., Shao, S. J., Liu, Y., & Liu, Z. H. (2018). Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China. Kidney Dis (Basel), 4, 10\u201319. https:\/\/doi.org\/10.1159\/000484717","journal-title":"Kidney Dis (Basel)"},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000348638","volume":"181","author":"X Pan","year":"2013","unstructured":"Pan, X., Xu, J., Ren, H., Zhang, W., Xu, Y., Shen, P., Li, X., Wang, W., Chen, X., Wu, P., Feng, X., Hao, C., & Chen, N. (2013). Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: A single-center study in China. Contributions to Nephrology, 181, 22\u201330. https:\/\/doi.org\/10.1159\/000348638","journal-title":"Contributions to Nephrology"},{"key":"934_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107376","volume":"94","author":"P Dai","year":"2021","unstructured":"Dai, P., Xie, W., Yu, X., Sun, J., Wang, S., & Kawuki, J. (2021). Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: A network meta-analysis and cost-effectiveness analysis. International Immunopharmacology, 94, 107376. https:\/\/doi.org\/10.1016\/j.intimp.2021.107376","journal-title":"International Immunopharmacology"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"WG Couser","year":"2017","unstructured":"Couser, W. G. (2017). Primary Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 12, 983\u2013997. https:\/\/doi.org\/10.2215\/CJN.11761116","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/j.semdp.2020.01.001","volume":"37","author":"Q Cai","year":"2020","unstructured":"Cai, Q., & Hendricks, A. R. (2020). Membranous nephropathy: A ten-year journey of discoveries. Seminars in Diagnostic Pathology, 37, 116\u2013120. https:\/\/doi.org\/10.1053\/j.semdp.2020.01.001","journal-title":"Seminars in Diagnostic Pathology"},{"key":"934_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3969\/j.issn.1671-2390.2019.07.001","volume":"19","author":"Z Xie","year":"2019","unstructured":"Xie, Z., Shi, W., Liang, X., Li, Z., Dong, W., Chen, Y., Tao, Y., Li, R., Wu, Y., & Liang, H. (2019). Evolution of chronic glomerular disease spectrum and epidemiological characteristics of membranous nephropathy. Journal of Clinical Nephrology, 19, 471\u2013476. https:\/\/doi.org\/10.3969\/j.issn.1671-2390.2019.07.001","journal-title":"Journal of Clinical Nephrology"},{"key":"934_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/nep.12542","volume":"20","author":"P Zhu","year":"2015","unstructured":"Zhu, P., Zhou, F. D., Wang, S. X., Zhao, M. H., & Wang, H. Y. (2015). Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: A 10-year renal biopsy study from a single Chinese nephrology centre. Nephrology (Carlton, Vic.), 20, 560\u2013566. https:\/\/doi.org\/10.1111\/nep.12542","journal-title":"Nephrology (Carlton, Vic.)"},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3389\/fimmu.2020.01846","volume":"11","author":"W Liu","year":"2020","unstructured":"Liu, W., Gao, C., Liu, Z., Dai, H., Feng, Z., Dong, Z., Zheng, Y., Gao, Y., Tian, X., & Liu, B. (2020). Idiopathic Membranous Nephropathy: Glomerular pathological pattern caused by extrarenal immunity activity. Frontiers in Immunology, 11, 1846. https:\/\/doi.org\/10.3389\/fimmu.2020.01846","journal-title":"Frontiers in Immunology"},{"key":"934_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad063c_6502","author":"V Tiwari","year":"2023","unstructured":"Tiwari, V., Jain, A., & Gupta, A. (2023). #6502 ETIOLOGICAL SPECTRUM OF MEMBRANOUS NEPHROPATHY. Nephrology Dialysis Transplantation. https:\/\/doi.org\/10.1093\/ndt\/gfad063c_6502","journal-title":"Nephrology Dialysis Transplantation"},{"key":"934_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.medcli.2021.02.010","volume":"157","author":"JE Rojas-Rivera","year":"2021","unstructured":"Rojas-Rivera, J. E., & Ortiz Arduan, A. (2021). Primary membranous nephropathy in the era of autoantibodies and biological therapies. Medicina Cl\u00ednica (Barcelona), 157, 121\u2013129. https:\/\/doi.org\/10.1016\/j.medcli.2021.02.010","journal-title":"Medicina Cl\u00ednica (Barcelona)"},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1073\/pnas.79.18.5557","volume":"79","author":"D Kerjaschki","year":"1982","unstructured":"Kerjaschki, D., & Farquhar, M. G. (1982). The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A, 79, 5557\u20135561. https:\/\/doi.org\/10.1073\/pnas.79.18.5557","journal-title":"Proc Natl Acad Sci U S A"},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.157.2.667","volume":"157","author":"D Kerjaschki","year":"1983","unstructured":"Kerjaschki, D., & Farquhar, M. G. (1983). Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. Journal of Experimental Medicine, 157, 667\u2013686. https:\/\/doi.org\/10.1084\/jem.157.2.667","journal-title":"Journal of Experimental Medicine"},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa012895","volume":"346","author":"H Debiec","year":"2002","unstructured":"Debiec, H., Guigonis, V., Mougenot, B., Decobert, F., Haymann, J.-P., Bensman, A., Desch\u00eanes, G., & Ronco, P. M. (2002). Antenatal Membranous Glomerulonephritis Due to Anti-Neutral Endopeptidase Antibodies. New England Journal of Medicine, 346, 2053\u20132060. https:\/\/doi.org\/10.1056\/NEJMoa012895","journal-title":"New England Journal of Medicine"},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck, L. H., Jr., Bonegio, R. G., Lambeau, G., Beck, D. M., Powell, D. W., Cummins, T. D., Klein, J. B., & Salant, D. J. (2009). M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New England Journal of Medicine, 361, 11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa0810457","journal-title":"New England Journal of Medicine"},{"key":"934_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.770902","volume":"12","author":"Z Dong","year":"2022","unstructured":"Dong, Z., Dai, H., Liu, W., Jiang, H., Feng, Z., Liu, F., Zhao, Q., Rui, H., Liu, W. J., & Liu, B. (2022). Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus Nephritis Using Integrated Bioinformatics Analysis. Frontiers in Genetics, 12, 770902. https:\/\/doi.org\/10.3389\/fgene.2021.770902","journal-title":"Frontiers in Genetics"},{"key":"934_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/nep.13691","volume":"25","author":"Z Xie","year":"2020","unstructured":"Xie, Z., Dong, W., Li, Z., Chen, Y., Song, L., Li, R., Wu, Y., Fu, L., Liang, H., Tao, Y., Xie, J., Wang, W., Liu, S., Ye, Z., Shi, W., & Liang, X. (2020). Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study. Nephrology (Carlton, Vic.), 25, 219\u2013229. https:\/\/doi.org\/10.1111\/nep.13691","journal-title":"Nephrology (Carlton, Vic.)"},{"key":"934_CR20","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","volume":"11","author":"J Xie","year":"2020","unstructured":"Xie, J., Liu, L.A.-O., Mladkova, N., Li, Y., Ren, H., Wang, W., Cui, Z., Lin, L., Hu, X., Yu, X., Xu, J., Liu, G., Caliskan, Y., Sidore, C., Balderes, O., Rosen, R. J., Bodria, M., Zanoni, F., Zhang, J.A.-O., \u2026 Kiryluk, K.A.-O. (2020). The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. Nature Communications, 11, 1600. https:\/\/doi.org\/10.1038\/s41467-020-15383-w","journal-title":"Nature Communications"},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas, N. M., Beck, L. H., Jr., Meyer-Schwesinger, C., Seitz-Polski, B., Ma, H., Zahner, G., Dolla, G., Hoxha, E., Helmchen, U., Dabert-Gay, A. S., Debayle, D., Merchant, M., Klein, J., Salant, D. J., Stahl, R. A. K., & Lambeau, G. (2014). Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. New England Journal of Medicine, 371, 2277\u20132287. https:\/\/doi.org\/10.1056\/NEJMoa1409354","journal-title":"New England Journal of Medicine"},{"key":"934_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108976","volume":"237","author":"I Nieto-Ganan","year":"2022","unstructured":"Nieto-Ganan, I., Iturrieta-Zuazo, I., Rita, C., & Carrasco-Sayalero, A. (2022). Revisiting immunological and clinical aspects of membranous nephropathy. Clinical Immunology, 237, 108976. https:\/\/doi.org\/10.1016\/j.clim.2022.108976","journal-title":"Clinical Immunology"},{"key":"934_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrneph.2014.227","volume":"11","author":"SJ Allison","year":"2015","unstructured":"Allison, S. J. (2015). Glomerular disease: Thrombospondin type-1 domain-containing 7A-a new player in membranous nephropathy. Nature Reviews Nephrology, 11, 63. https:\/\/doi.org\/10.1038\/nrneph.2014.227","journal-title":"Nature Reviews Nephrology"},{"key":"934_CR24","doi-asserted-by":"publisher","first-page":"1900099","DOI":"10.1002\/gch2.201900099","volume":"4","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Zheng, S., Ma, C., Lian, Y., Zheng, X., Guan, P., Wang, B., Gong, X., Gao, F., Liang, L., & Xu, D. (2020). Meta-Analysis of the Diagnostic Efficiency of THSD7A-AB for the Diagnosis of Idiopathic Membranous Nephropathy. Glob Chall, 4, 1900099. https:\/\/doi.org\/10.1002\/gch2.201900099","journal-title":"Glob Chall"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/biom10020319","volume":"10","author":"SM Maifata","year":"2020","unstructured":"Maifata, S. M., Hod, R., Zakaria, F., & Ghani, F. A. (2020). Role of Serum and Urine Biomarkers (PLA(2)R and THSD7A) in diagnosis, monitoring and prognostication of primary membranous glomerulonephritis. Biomolecules, 10, 319. https:\/\/doi.org\/10.3390\/biom10020319","journal-title":"Biomolecules"},{"key":"934_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.kint.2023.01.001","volume":"103","author":"TN Caza","year":"2023","unstructured":"Caza, T. N., Storey, A. J., Hassen, S. I., Herzog, C., Edmondson, R. D., Arthur, J. M., Kenan, D. J., & Larsen, C. P. (2023). Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry. Kidney International, 103, 593\u2013606. https:\/\/doi.org\/10.1016\/j.kint.2023.01.001","journal-title":"Kidney International"},{"key":"934_CR27","doi-asserted-by":"publisher","DOI":"10.1159\/000529437","author":"HYG Choung","year":"2023","unstructured":"Choung, H. Y. G., Moore, C., Le, T. H., Guirguis, P., McKeown, J. M., Jean-Gilles, J., & Goldman, B. (2023). The clinicopathologic spectrum of membranous nephropathy with lupus-like features. Nephron. https:\/\/doi.org\/10.1159\/000529437","journal-title":"Nephron"},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/dnares\/1.1.27","volume":"1","author":"N Nomura","year":"1994","unstructured":"Nomura, N., Miyajima, N., Sazuka, T., Tanaka, A., Kawarabayasi, Y., Sato, S., Nagase, T., Seki, N., Ishikawa, K.-I., & Tabata, S. (1994). Prediction of the Coding Sequences of Unidentified Human Genes. I. The Coding Sequences of 40 New Genes (KIAA0001-KIAA0040) Deduced by Analysis of Randomly Sampled cDNA Clones from Human Immature Myeloid Cell Line KG-1. DNA Research, 1, 27\u201335. https:\/\/doi.org\/10.1093\/dnares\/1.1.27","journal-title":"DNA Research"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/dnares\/9.3.99","volume":"9","author":"D Nakajima","year":"2002","unstructured":"Nakajima, D., Okazaki, N., Yamakawa, H., Kikuno, R., Ohara, O., & Nagase, T. (2002). Construction of Expression-ready cDNA Clones for KIAA Genes: Manual Curation of 330 KIAA cDNA Clones. DNA Research, 9, 99\u2013106. https:\/\/doi.org\/10.1093\/dnares\/9.3.99","journal-title":"DNA Research"},{"key":"934_CR30","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.kint.2018.10.024","volume":"95","author":"C Zaghrini","year":"2019","unstructured":"Zaghrini, C., Seitz-Polski, B., Justino, J., Dolla, G., Payre, C., Jourde-Chiche, N., Van de Logt, A. E., Booth, C., Rigby, E., Lonnbro-Widgren, J., Nystrom, J., Mariat, C., Cui, Z., Wetzels, J. F. M., Ghiggeri, G., Beck, L. H., Jr., Ronco, P., Debiec, H., & Lambeau, G. (2019). Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy. Kidney International, 95, 666\u2013679. https:\/\/doi.org\/10.1016\/j.kint.2018.10.024","journal-title":"Kidney International"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/prot.25640","volume":"87","author":"SV Stoddard","year":"2019","unstructured":"Stoddard, S. V., Welsh, C. L., Palopoli, M. M., Stoddard, S. D., Aramandla, M. P., Patel, R. M., Ma, H., & Beck, L. H., Jr. (2019). Structure and function insights garnered from in silico modeling of the thrombospondin type-1 domain-containing 7A antigen. Proteins, 87, 136\u2013145. https:\/\/doi.org\/10.1002\/prot.25640","journal-title":"Proteins"},{"key":"934_CR32","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1681\/ASN.2017070805","volume":"29","author":"L Seifert","year":"2018","unstructured":"Seifert, L., Hoxha, E., Eichhoff, A. M., Zahner, G., Dehde, S., Reinhard, L., Koch-Nolte, F., Stahl, R. A. K., & Tomas, N. M. (2018). The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy. Journal of the American Society of Nephrology, 29, 1536\u20131548. https:\/\/doi.org\/10.1681\/ASN.2017070805","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.03.539264","author":"A Bochel","year":"2023","unstructured":"Bochel, A., Mortensen, S. A., Seifert, L., Hengel, F. E., Jeffries, C. M., Chojnowski, G., Kretz, O., Huber, T. B., Tomas, N. M., & Wilmanns, M. (2023). Structure of the N-terminal didomain d1_d2 of the Thrombospondin type-1 domain-containing 7A. bioRxiv. https:\/\/doi.org\/10.1101\/2023.05.03.539264","journal-title":"bioRxiv"},{"key":"934_CR34","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/dvdy.22641","volume":"240","author":"CH Wang","year":"2011","unstructured":"Wang, C. H., Chen, I. H., Kuo, M. W., Su, P. T., Lai, Z. Y., Wang, C. H., Huang, W. C., Hoffman, J., Kuo, C. J., You, M. S., & Chuang, Y. J. (2011). Zebrafish Thsd7a is a neural protein required for angiogenic patterning during development. Developmental Dynamics, 240, 1412\u20131421. https:\/\/doi.org\/10.1002\/dvdy.22641","journal-title":"Developmental Dynamics"},{"key":"934_CR35","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1681\/ASN.2018090941","volume":"30","author":"J Herwig","year":"2019","unstructured":"Herwig, J., Skuza, S., Sachs, W., Sachs, M., Failla, A. V., Rune, G., Meyer, T. N., Fester, L., & Meyer-Schwesinger, C. (2019). Thrombospondin Type 1 Domain-Containing 7A localizes to the slit diaphragm and stabilizes membrane dynamics of fully differentiated podocytes. Journal of the American Society of Nephrology, 30, 824\u2013839. https:\/\/doi.org\/10.1681\/ASN.2018090941","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jcp.21990","volume":"222","author":"C-H Wang","year":"2010","unstructured":"Wang, C.-H., Su, P.-T., Du, X.-Y., Kuo, M.-W., Lin, C.-Y., Yang, C.-C., Chan, H.-S., Chang, S.-J., Kuo, C., Seo, K., Leung, L. L., & Chuang, Y.-J. (2010). Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation. Journal of Cellular Physiology, 222, 685\u2013694. https:\/\/doi.org\/10.1002\/jcp.21990","journal-title":"Journal of Cellular Physiology"},{"key":"934_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-016-0277-9","volume":"23","author":"LY-M Liu","year":"2016","unstructured":"Liu, L.Y.-M., Lin, M.-H., Lai, Z.-Y., Jiang, J.-P., Huang, Y.-C., Jao, L.-E., & Chuang, Y.-J. (2016). Motor neuron-derived Thsd7a is essential for zebrafish vascular development via the Notch-dll4 signaling pathway. Journal of Biomedical Science, 23, 1\u201311. https:\/\/doi.org\/10.1186\/s12929-016-0277-9","journal-title":"Journal of Biomedical Science"},{"key":"934_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029000","volume":"6","author":"MW Kuo","year":"2011","unstructured":"Kuo, M. W., Wang, C. H., Wu, H. C., Chang, S. J., & Chuang, Y. J. (2011). Soluble THSD7A is an N-glycoprotein that promotes endothelial cell migration and tube formation in angiogenesis. PLoS ONE, 6, e29000. https:\/\/doi.org\/10.1371\/journal.pone.0029000","journal-title":"PLoS ONE"},{"key":"934_CR39","doi-asserted-by":"publisher","first-page":"60539","DOI":"10.18632\/oncotarget.16966","volume":"8","author":"Z Hou","year":"2017","unstructured":"Hou, Z., Abudureheman, A., Wang, L., Hasim, A., Ainiwaer, J., Zhang, H., Niyaz, M., Upur, H., & Sheyhidin, I. (2017). Expression, prognosis and functional role of Thsd7a in esophageal squamous cell carcinoma of Kazakh patients, Xinjiang. Oncotarget, 8, 60539\u201360557. https:\/\/doi.org\/10.18632\/oncotarget.16966","journal-title":"Oncotarget"},{"key":"934_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13855","volume":"75","author":"B Kaya","year":"2021","unstructured":"Kaya, B., Paydas, S., Balal, M., Eren Erdogan, K., & Gonlusen, G. (2021). Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings. International Journal of Clinical Practice, 75, e13855. https:\/\/doi.org\/10.1111\/ijcp.13855","journal-title":"International Journal of Clinical Practice"},{"key":"934_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00467-019-04425-1","volume":"36","author":"L Safar-Boueri","year":"2021","unstructured":"Safar-Boueri, L., Piya, A., Beck, L. H., Jr., & Ayalon, R. (2021). Membranous nephropathy: Diagnosis, treatment, and monitoring in the post-PLA2R era. Pediatric Nephrology(Berlin, Germany), 36, 19\u201330. https:\/\/doi.org\/10.1007\/s00467-019-04425-1","journal-title":"Pediatric Nephrology(Berlin, Germany)"},{"key":"934_CR42","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.13898\/j.cnki.issn.1000-2200.2022.09.003","volume":"47","author":"C Cui","year":"2022","unstructured":"Cui, C., Gao, P., Xu, P., Wu, X., Pan, Y., Liu, L., & Chen, W. (2022). Evaluation on clinical application of PLA2 R and THSD7 A in idiopathic membranous nephropathy. Journal of Bengbu Medical College, 47, 1167\u20131171. https:\/\/doi.org\/10.13898\/j.cnki.issn.1000-2200.2022.09.003","journal-title":"Journal of Bengbu Medical College"},{"key":"934_CR43","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1172\/JCI85265","volume":"126","author":"NM Tomas","year":"2016","unstructured":"Tomas, N. M., Hoxha, E., Reinicke, A. T., Fester, L., Helmchen, U., Gerth, J., Bachmann, F., Budde, K., Koch-Nolte, F., Zahner, G., Rune, G., Lambeau, G., Meyer-Schwesinger, C., & Stahl, R. A. (2016). Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy. The Journal of Clinical Investigation, 126, 2519\u20132532. https:\/\/doi.org\/10.1172\/JCI85265","journal-title":"The Journal of Clinical Investigation"},{"key":"934_CR44","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1681\/ASN.2017010030","volume":"28","author":"NM Tomas","year":"2017","unstructured":"Tomas, N. M., Meyer-Schwesinger, C., von Spiegel, H., Kotb, A. M., Zahner, G., Hoxha, E., Helmchen, U., Endlich, N., Koch-Nolte, F., & Stahl, R. A. K. (2017). A heterologous model of thrombospondin type 1 domain-containing 7A-Associated Membranous Nephropathy. Journal of the American Society of Nephrology, 28, 3262\u20133277. https:\/\/doi.org\/10.1681\/ASN.2017010030","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR45","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/S0140-6736(15)60731-0","volume":"385","author":"P Ronco","year":"2015","unstructured":"Ronco, P., & Debiec, H. (2015). Pathophysiological advances in membranous nephropathy: Time for a shift in patient\u2019s care. Lancet, 385, 1983\u20131992. https:\/\/doi.org\/10.1016\/S0140-6736(15)60731-0","journal-title":"Lancet"},{"key":"934_CR46","doi-asserted-by":"publisher","unstructured":"Nakamura, R., Tohnai, G., Nakatochi, M., Atsuta, N., Watanabe, H., Ito, D., Katsuno, M., Hirakawa, A., Izumi, Y., Morita, M., Hirayama, T., Kano, O., Kanai, K., Hattori, N., Taniguchi, A., Suzuki, N., Aoki, M., Iwata, I., Yabe, I., Shibuya, K., Kuwabara, S., Oda, M., Hashimoto, R., Aiba, I., Ishihara, T., Onodera, O., Yamashita, T., Abe, K., Mizoguchi, K., Shimizu, T., Ikeda, Y., Yokota, T., Hasegawa, K., Tanaka, F., Nakashima, K., Kaji, R., Niwa, J. I., Doyu, M., Terao, C., Ikegawa, S., Fujimori, K., Nakamura, S., Ozawa, F., Morimoto, S., Onodera, K., Ito, T., Okada, Y., Okano, H., Sobue, G. and Japanese Consortium for Amyotrophic Lateral Sclerosis research study, g. (2023). Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: A genome-wide association study and verification in iPSC-derived motor neurons from patients. Journal of Neurology, Neurosurgery and Psychiatry,\u00a094, 816\u2013824. https:\/\/doi.org\/10.1136\/jnnp-2022-330851","DOI":"10.1136\/jnnp-2022-330851"},{"key":"934_CR47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1681\/ASN.2017060664","volume":"29","author":"CP Larsen","year":"2018","unstructured":"Larsen, C. P., Trivin-Avillach, C., Coles, P., Collins, A. B., Merchant, M., Ma, H., Wilkey, D. W., Ambruzs, J. M., Messias, N. C., Cossey, L. N., Rosales, I. A., Wooldridge, T., Walker, P. D., Colvin, R. B., Klein, J., Salant, D. J., & Beck, L. H., Jr. (2018). LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease. Journal of the American Society of Nephrology, 29, 644\u2013653. https:\/\/doi.org\/10.1681\/ASN.2017060664","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR48","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/ndt\/13.10.2501","volume":"13","author":"M Kobayashi","year":"1998","unstructured":"Kobayashi, M., Muro, K., Yoh, K., Kondoh, M., Iwabuchi, S., Hirayama, K., Ishizu, T., Kikuchi, S., Yamaguchi, N., & Koyama, A. (1998). Effects of FK506 on experimental membranous glomerulonephritis induced by cationized bovine serum albumin in rats. Nephrology Dialysis Transplantation, 13, 2501\u20132508. https:\/\/doi.org\/10.1093\/ndt\/13.10.2501","journal-title":"Nephrology Dialysis Transplantation"},{"key":"934_CR49","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.kint.2019.10.022","volume":"97","author":"C Meyer-Schwesinger","year":"2020","unstructured":"Meyer-Schwesinger, C., Tomas, N. M., Dehde, S., Seifert, L., Hermans-Borgmeyer, I., Wiech, T., Koch-Nolte, F., Huber, T. B., & Zahner, G. (2020). A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients. Kidney International, 97, 913\u2013919. https:\/\/doi.org\/10.1016\/j.kint.2019.10.022","journal-title":"Kidney International"},{"key":"934_CR50","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.3892\/mmr.2020.11014","volume":"21","author":"H Jiang","year":"2020","unstructured":"Jiang, H., Feng, Z., Zhu, Z., Xia, C., Zhang, W., Guo, J., Liu, B. L., Wang, Y., Liu, Y., & Liu, W. (2020). Advances of the experimental models of idiopathic membranous nephropathy (Review). Molecular Medicine Reports, 21, 1993\u20132005. https:\/\/doi.org\/10.3892\/mmr.2020.11014","journal-title":"Molecular Medicine Reports"},{"key":"934_CR51","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","volume":"19","author":"DS Pisetsky","year":"2023","unstructured":"Pisetsky, D. S. (2023). Pathogenesis of autoimmune disease. Nature Reviews. Nephrology, 19, 509\u2013524. https:\/\/doi.org\/10.1038\/s41581-023-00720-1","journal-title":"Nature Reviews. Nephrology"},{"key":"934_CR52","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41581-022-00564-1","volume":"18","author":"E Hoxha","year":"2022","unstructured":"Hoxha, E., Reinhard, L., & Stahl, R. A. K. (2022). Membranous nephropathy: New pathogenic mechanisms and their clinical implications. Nature Reviews. Nephrology, 18, 466\u2013478. https:\/\/doi.org\/10.1038\/s41581-022-00564-1","journal-title":"Nature Reviews. Nephrology"},{"key":"934_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.969930","volume":"13","author":"H Miao","year":"2022","unstructured":"Miao, H., Zhang, Y., Yu, X., Zou, L., & Zhao, Y. (2022). Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy. Frontiers in Pharmacology, 13, 969930. https:\/\/doi.org\/10.3389\/fphar.2022.969930","journal-title":"Frontiers in Pharmacology"},{"key":"934_CR54","first-page":"246","volume":"8","author":"N Yang","year":"2019","unstructured":"Yang, N., & Wang, L. (2019). Clinical significance of PLA2R antibody and THSD7A antibody in serum and urine of patients with idiopathic membranous nephropathy. Chinese Journal of Kidney Disease Investigation (Electronic Edition), 8, 246\u2013252. CNKI:SUN:SHSB.0.2019-06-005.","journal-title":"Chinese Journal of Kidney Disease Investigation (Electronic Edition)"},{"key":"934_CR55","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ekir.2020.02.1033","volume":"5","author":"V Brglez","year":"2020","unstructured":"Brglez, V., Boyer-Suavet, S., & Seitz-Polski, B. (2020). Complement pathways in membranous nephropathy: Complex and multifactorial. Kidney Int Rep, 5, 572\u2013574. https:\/\/doi.org\/10.1016\/j.ekir.2020.02.1033","journal-title":"Kidney Int Rep"},{"key":"934_CR56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41467-023-36068-0","volume":"14","author":"L Seifert","year":"2023","unstructured":"Seifert, L., Zahner, G., Meyer-Schwesinger, C., Hickstein, N., Dehde, S., Wulf, S., Kollner, S. M. S., Lucas, R., Kylies, D., Froembling, S., Zielinski, S., Kretz, O., Borodovsky, A., Biniaminov, S., Wang, Y., Cheng, H., Koch-Nolte, F., Zipfel, P. F., Hopfer, H., \u2026 Tomas, N. M. (2023). The classical pathway triggers pathogenic complement activation in membranous nephropathy. Nature Communications, 14, 473. https:\/\/doi.org\/10.1038\/s41467-023-36068-0","journal-title":"Nature Communications"},{"key":"934_CR57","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180131","author":"Z Wang","year":"2018","unstructured":"Wang, Z., Wen, L., Dou, Y., & Zhao, Z. (2018). Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway. Bioscience Reports. https:\/\/doi.org\/10.1042\/BSR20180131"},{"key":"934_CR58","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2016010050","volume":"28","author":"E Hoxha","year":"2017","unstructured":"Hoxha, E., Beck, L. H., Jr., Wiech, T., Tomas, N. M., Probst, C., Mindorf, S., Meyer-Schwesinger, C., Zahner, G., Stahl, P. R., Schopper, R., Panzer, U., Harendza, S., Helmchen, U., Salant, D. J., & Stahl, R. A. (2017). An indirect immunofluorescence method facilitates detection of thrombospondin type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. Journal of the American Society of Nephrology, 28, 520\u2013531. https:\/\/doi.org\/10.1681\/ASN.2016010050","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158154","volume":"11","author":"K Hihara","year":"2016","unstructured":"Hihara, K., Iyoda, M., Tachibana, S., Iseri, K., Saito, T., Yamamoto, Y., Suzuki, T., Wada, Y., Matsumoto, K., & Shibata, T. (2016). Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy. PLoS ONE, 11, e0158154. https:\/\/doi.org\/10.1371\/journal.pone.0158154","journal-title":"PLoS ONE"},{"key":"934_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.952235","volume":"13","author":"P Manral","year":"2022","unstructured":"Manral, P., Caza, T. N., Storey, A. J., Beck, L. H., Jr., & Borza, D. B. (2022). The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy. Frontiers in Immunology, 13, 952235. https:\/\/doi.org\/10.3389\/fimmu.2022.952235","journal-title":"Frontiers in Immunology"},{"key":"934_CR61","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1159\/000508665","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Liu, Y., Liang, L., Liu, L., Tang, X., Tang, L., Chen, P., Chen, J., Wang, Z., Cao, W., Chen, Q., Zhao, N., & Xu, D. (2020). Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy. Kidney & Blood Pressure Research, 45, 713\u2013726. https:\/\/doi.org\/10.1159\/000508665","journal-title":"Kidney & Blood Pressure Research"},{"key":"934_CR62","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1144603","volume":"317","author":"M van der Neut Kolfschoten","year":"2007","unstructured":"van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martinez-Martinez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vink, T., Aarden, L. A., De Baets, M. H., van de Winkel, J. G., Aalberse, R. C., & Parren, P. W. (2007). Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science, 317, 1554\u20131557. https:\/\/doi.org\/10.1126\/science.1144603","journal-title":"Science"},{"key":"934_CR63","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s12026-016-8790-1","volume":"64","author":"Y Yang","year":"2016","unstructured":"Yang, Y., Wang, C., Jin, L., He, F., Li, C., Gao, Q., Chen, G., He, Z., Song, M., Zhou, Z., Shan, F., Qi, K., & Ma, L. (2016). IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: An inspiration from a cross-sectional study. Immunologic Research, 64, 919\u2013930. https:\/\/doi.org\/10.1007\/s12026-016-8790-1","journal-title":"Immunologic Research"},{"key":"934_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00428-019-02558-0","volume":"474","author":"S Hara","year":"2019","unstructured":"Hara, S., Tsuji, T., Fukasawa, Y., Hisano, S., Morito, S., Hyodo, T., Goto, S., Nishi, S., Yoshimoto, A., & Itoh, T. (2019). Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy. Virchows Archiv, 474, 735\u2013743. https:\/\/doi.org\/10.1007\/s00428-019-02558-0","journal-title":"Virchows Archiv"},{"key":"934_CR65","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MNH.0000000000000459","volume":"28","author":"DJ Salant","year":"2019","unstructured":"Salant, D. J. (2019). Unmet challenges in membranous nephropathy. Current Opinion in Nephrology and Hypertension, 28, 70\u201376. https:\/\/doi.org\/10.1097\/MNH.0000000000000459","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"934_CR66","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1053\/j.ajkd.2018.10.009","volume":"73","author":"A Matsumoto","year":"2019","unstructured":"Matsumoto, A., Matsui, I., Namba, T., Sakaguchi, Y., Mizuno, H., Shirayama, Y., Shimada, K., Hashimoto, N., Doi, Y., Yamaguchi, S., Kubota, K., Oka, T., Mori, D., Akiyama, S., Hamano, T., Mizui, M., Takabatake, Y., Kaneko, T., & Isaka, Y. (2019). VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases. American Journal of Kidney Diseases, 73, 880\u2013885. https:\/\/doi.org\/10.1053\/j.ajkd.2018.10.009","journal-title":"American Journal of Kidney Diseases"},{"key":"934_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/diagnostics13010017","volume":"13","author":"LC Battaini","year":"2022","unstructured":"Battaini, L. C., Ranzani, O. T., Marcal, L. J., Antonangelo, L., Jorge, L. B., Bitencourt, C. D., Woronik, V., Malheiros, D. M. A., & Yu, L. (2022). Determination of Anti-Phospholipase A2 and Anti-Thrombospondin Type 1 Domain-Containing Protein 7A in Latin Patients with Membranous Nephropathy. Diagnostics (Basel), 13, 17. https:\/\/doi.org\/10.3390\/diagnostics13010017","journal-title":"Diagnostics (Basel)"},{"key":"934_CR68","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/modpathol.2012.207","volume":"26","author":"CP Larsen","year":"2013","unstructured":"Larsen, C. P., Messias, N. C., Silva, F. G., Messias, E., & Walker, P. D. (2013). Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Modern Pathology, 26, 709\u2013715. https:\/\/doi.org\/10.1038\/modpathol.2012.207","journal-title":"Modern Pathology"},{"key":"934_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156263","volume":"11","author":"H-R Dong","year":"2016","unstructured":"Dong, H.-R., Wang, Y.-Y., Cheng, X.-H., Wang, G.-Q., Sun, L.-J., Cheng, H., & Chen, Y.-P. (2016). Retrospective study of phospholipase A2 receptor and IgG subclasses in glomerular deposits in Chinese patients with membranous nephropathy. PLoS ONE, 11, e0156263. https:\/\/doi.org\/10.1371\/journal.pone.0156263","journal-title":"PLoS ONE"},{"key":"934_CR70","doi-asserted-by":"publisher","first-page":"42","DOI":"10.11969\/j.issn.1673-548X.2020.08.011","volume":"49","author":"X Wang","year":"2020","unstructured":"Wang, X., Chen, C., Ding, G., Wang, H., Liang, W., Yang, H., & Zhu, J. (2020). Clinical and Pathological Characteristics of THSD7A Related Idiopathic Mem Branous Nephropathy. Journal of Medical Research, 49, 42\u201346. https:\/\/doi.org\/10.11969\/j.issn.1673-548X.2020.08.011","journal-title":"Journal of Medical Research"},{"key":"934_CR71","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMc1511702","volume":"374","author":"E Hoxha","year":"2016","unstructured":"Hoxha, E., Wiech, T., Stahl, P. R., Zahner, G., Tomas, N. M., Meyer-Schwesinger, C., Wenzel, U., Janneck, M., Steinmetz, O. M., Panzer, U., Harendza, S., & Stahl, R. A. K. (2016). A Mechanism for Cancer-Associated Membranous Nephropathy. New England Journal of Medicine, 374, 1995\u20131996. https:\/\/doi.org\/10.1056\/NEJMc1511702","journal-title":"New England Journal of Medicine"},{"key":"934_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845767","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu, Q., Liu, J., Lin, B., Zhang, Y., Ma, M., Yang, M., & Qin, X. (2022). Novel Biomarkers in Membranous Nephropathy. Frontiers in Immunology, 13, 845767. https:\/\/doi.org\/10.3389\/fimmu.2022.845767","journal-title":"Frontiers in Immunology"},{"key":"934_CR73","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10157-020-02011-6","volume":"25","author":"HH Yeter","year":"2021","unstructured":"Yeter, H. H., Isik Gonul, I., Eraslan, E., Karacalik, C., Ogut, B., & Guz, G. (2021). Effects of phospholipase A 2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy. Clinical and Experimental Nephrology, 25, 488\u2013500. https:\/\/doi.org\/10.1007\/s10157-020-02011-6","journal-title":"Clinical and Experimental Nephrology"},{"key":"934_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03561-w","author":"D Gao","year":"2023","unstructured":"Gao, D., Lu, L. P., & Zhao, Z. G. (2023). Diagnostic utility of serum and urine biomarkers in idiopathic membranous nephropathy: A systematic review and meta-analysis. International Urology and Nephrology. https:\/\/doi.org\/10.1007\/s11255-023-03561-w","journal-title":"International Urology and Nephrology"},{"key":"934_CR75","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2169\/internalmedicine.55.6726","volume":"55","author":"T Iwakura","year":"2016","unstructured":"Iwakura, T., Fujigaki, Y., Katahashi, N., Sato, T., Ishigaki, S., Tsuji, N., Naito, Y., Isobe, S., Ono, M., Sakao, Y., Tsuji, T., Ohashi, N., Kato, A., Miyajima, H., & Yasuda, H. (2016). Membranous Nephropathy with an Enhanced Granular Expression of Thrombospondin Type-1 Domain-containing 7A in a Pregnant Woman. Internal Medicine, 55, 2663\u20132668. https:\/\/doi.org\/10.2169\/internalmedicine.55.6726","journal-title":"Internal Medicine"},{"key":"934_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138841","volume":"10","author":"T Iwakura","year":"2015","unstructured":"Iwakura, T., Ohashi, N., Kato, A., Baba, S., & Yasuda, H. (2015). Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy. PLoS ONE, 10, e0138841. https:\/\/doi.org\/10.1371\/journal.pone.0138841","journal-title":"PLoS ONE"},{"key":"934_CR77","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2215\/CJN.01460217","volume":"12","author":"J Wang","year":"2017","unstructured":"Wang, J., Cui, Z., Lu, J., Probst, C., Zhang, Y. M., Wang, X., Qu, Z., Wang, F., Meng, L. Q., Cheng, X. Y., Liu, G., Debiec, H., Ronco, P., & Zhao, M. H. (2017). Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 12, 1642\u20131651. https:\/\/doi.org\/10.2215\/CJN.01460217","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"934_CR78","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/0886022X.2018.1456457","volume":"40","author":"S Ren","year":"2018","unstructured":"Ren, S., Wu, C., Zhang, Y., Wang, A. Y., Li, G., Wang, L., & Hong, D. (2018). An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: A systematic review and meta-analysis of THSD7A in IMN. Renal Failure, 40, 306\u2013313. https:\/\/doi.org\/10.1080\/0886022X.2018.1456457","journal-title":"Renal Failure"},{"key":"934_CR79","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.pathol.2021.06.028","volume":"53","author":"K Hegerty","year":"2021","unstructured":"Hegerty, K., Gois, P., Ranganathan, D., Kassianos, A., Raghubar, A., & Francis, L. (2021). Thrombospondin type-1 domain-containing 7A and membranous nephropathy\u2013The first retrospective analysis of podocyte antigen prevalence and prognosis in an Australian cohort. Pathology, 53, S26. https:\/\/doi.org\/10.1016\/j.pathol.2021.06.028","journal-title":"Pathology"},{"key":"934_CR80","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00467-017-3817-y","volume":"33","author":"AK Dettmar","year":"2018","unstructured":"Dettmar, A. K., Wiech, T., Kemper, M. J., Soave, A., Rink, M., Oh, J., Stahl, R. A. K., Hoxha, E., & Pediatric, M. N. S. G. (2018). Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents. Pediatric Nephrology(Berlin, Germany), 33, 463\u2013472. https:\/\/doi.org\/10.1007\/s00467-017-3817-y","journal-title":"Pediatric Nephrology(Berlin, Germany)"},{"key":"934_CR81","doi-asserted-by":"publisher","first-page":"808","DOI":"10.14009\/j.issn.1672-2124.2019.07.013","volume":"19","author":"T Wang","year":"2019","unstructured":"Wang, T., Cai, L., Li, G., & Liu, X. (2019). Effects of Tacrolimus on Serum M-Type Phospholipase A2 Receptor and Thrombospondin Type-1 Domain-Containing 7A Expression in Patients with Idiopathic Membranous Nephropathy. Evaluation and Analysis of Drug-Use in Hospitals of China, 19, 808\u2013810. https:\/\/doi.org\/10.14009\/j.issn.1672-2124.2019.07.013","journal-title":"Evaluation and Analysis of Drug-Use in Hospitals of China"},{"key":"934_CR82","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3760\/cma.j.issn.1009-9158.2017.08.003","volume":"40","author":"Q Han","year":"2017","unstructured":"Han, Q., & Zhu, H. (2017). Clinical significance of serum PLA2R antibody and THSD7A antibody in idiopathic membranous nephropathy. Chinese Journal of Laboratory Medicine, 40, 564\u2013568. https:\/\/doi.org\/10.3760\/cma.j.issn.1009-9158.2017.08.003","journal-title":"Chinese Journal of Laboratory Medicine"},{"key":"934_CR83","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/modpathol.2016.32","volume":"29","author":"CP Larsen","year":"2016","unstructured":"Larsen, C. P., Cossey, L. N., & Beck, L. H. (2016). THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity. Modern Pathology, 29, 421\u2013426. https:\/\/doi.org\/10.1038\/modpathol.2016.32","journal-title":"Modern Pathology"},{"key":"934_CR84","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/modpathol.2017.163","volume":"31","author":"SG Sharma","year":"2018","unstructured":"Sharma, S. G., & Larsen, C. P. (2018). Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: A clinicopathological study. Modern Pathology, 31, 616\u2013622. https:\/\/doi.org\/10.1038\/modpathol.2017.163","journal-title":"Modern Pathology"},{"key":"934_CR85","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.12659\/MSM.909815","volume":"24","author":"D Zhang","year":"2018","unstructured":"Zhang, D., Zou, J., Zhang, C., Zhang, W., Lin, F., & Jiang, G. (2018). Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Medical Science Monitor, 24, 5076\u20135083. https:\/\/doi.org\/10.12659\/MSM.909815","journal-title":"Medical Science Monitor"},{"key":"934_CR86","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s11255-019-02146-w","volume":"51","author":"C Tian","year":"2019","unstructured":"Tian, C., Li, L., Liu, T., Qu, X., & Qiu, Y. (2019). Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy. International Urology and Nephrology, 51, 1371\u20131377. https:\/\/doi.org\/10.1007\/s11255-019-02146-w","journal-title":"International Urology and Nephrology"},{"key":"934_CR87","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.3390\/ijerph19095301","volume":"19","author":"I Smarz-Widelska","year":"2022","unstructured":"Smarz-Widelska, I., Chojeta, D., & Koziol, M. M. (2022). The Role of Anti-PLA(2)R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice. International Journal of Environmental Research and Public Health, 19, 5301. https:\/\/doi.org\/10.3390\/ijerph19095301","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"934_CR88","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/978-3-319-49379-4_16","volume-title":"Glomerulonephritis","author":"S Toth-Manikowski","year":"2019","unstructured":"Toth-Manikowski, S., & Beck, L. H. (2019). PLA2R- and THSD7A-Associated Primary Membranous Nephropathy. In H. Trachtman, L. C. Herlitz, E. V. Lerma, & J. J. Hogan (Eds.), Glomerulonephritis (pp. 301\u2013331). Springer International Publishing."},{"key":"934_CR89","first-page":"01","volume":"27","author":"Fouad, M. A., Mahedy, A. W., Mansou","year":"2020","unstructured":"Fouad, M. A., Mahedy, A. W., Mansour, A. E. and Fouad, N. A. (2020). Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study. EGYPTIAN JOURNAL OF IMMUNOLOGY, 27, 01\u201309.","journal-title":"EGYPTIAN JOURNAL OF IMMUNOLOGY"},{"key":"934_CR90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12882-019-1236-y","volume":"20","author":"S Taguchi","year":"2019","unstructured":"Taguchi, S., Koshikawa, Y., Ohyama, S., Miyachi, H., Ozawa, H., & Asada, H. (2019). Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: A case report. BMC Nephrology, 20, 43. https:\/\/doi.org\/10.1186\/s12882-019-1236-y","journal-title":"BMC Nephrology"},{"key":"934_CR91","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1681\/asn.2010111125","volume":"22","author":"LHJ Beck","year":"2011","unstructured":"Beck, L. H. J., Fervenza, F. C., Beck, D. M., Bonegio, R. G. B., Malik, F. A., Erickson, S. B., Cosio, F. G., Cattran, D. C., & Salant, D. J. (2011). Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy. Journal of the American Society of Nephrology, 22, 1543\u20131550. https:\/\/doi.org\/10.1681\/asn.2010111125","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR92","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/asn.2013040430","volume":"25","author":"E Hoxha","year":"2014","unstructured":"Hoxha, E., Thiele, I., Zahner, G., Panzer, U., Harendza, S., & Stahl, R. A. K. (2014). Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy. Journal of the American Society of Nephrology, 25, 1357\u20131366. https:\/\/doi.org\/10.1681\/asn.2013040430","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR93","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1590\/2175-8239-JBN-2019-0077","volume":"42","author":"DC Wanderley","year":"2019","unstructured":"Wanderley, D. C., Jones, B. D., Barbosa, F. A. M., & Araujo, S. A. (2019). A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy. Jornal Brasileiro de Nefrologia, 42, 254\u2013258. https:\/\/doi.org\/10.1590\/2175-8239-JBN-2019-0077","journal-title":"Jornal Brasileiro de Nefrologia"},{"key":"934_CR94","doi-asserted-by":"publisher","first-page":"16188","DOI":"10.1038\/s41598-021-94921-y","volume":"11","author":"L Reinhard","year":"2021","unstructured":"Reinhard, L., Thomas, C., Machalitza, M., Lattwein, E., Weiss, L. S., Vitu, J., Wiech, T., Stahl, R. A. K., & Hoxha, E. (2021). Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy. Scientific Reports, 11, 16188. https:\/\/doi.org\/10.1038\/s41598-021-94921-y","journal-title":"Scientific Reports"},{"key":"934_CR95","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11255-018-02068-z","volume":"51","author":"T Wang","year":"2019","unstructured":"Wang, T., Zhang, Y., Liu, M., Kang, X., Kang, L., & Zhang, H. (2019). THSD7A as a marker for paraneoplastic membranous nephropathy. International Urology and Nephrology, 51, 371\u2013373. https:\/\/doi.org\/10.1007\/s11255-018-02068-z","journal-title":"International Urology and Nephrology"},{"key":"934_CR96","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1369\/0022155414561498","volume":"63","author":"H Yoon","year":"2015","unstructured":"Yoon, H., Dehart, J. P., Murphy, J. M., & Lim, S. T. (2015). Understanding the roles of FAK in cancer: Inhibitors, genetic models, and new insights. Journal of Histochemistry and Cytochemistry, 63, 114\u2013128. https:\/\/doi.org\/10.1369\/0022155414561498","journal-title":"Journal of Histochemistry and Cytochemistry"},{"key":"934_CR97","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/diagnostics13020221","volume":"13","author":"FA Flockerzi","year":"2023","unstructured":"Flockerzi, F. A., Hohneck, J., Saar, M., Bohle, R. M., & Stahl, P. R. (2023). THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer. Diagnostics (Basel), 13, 221. https:\/\/doi.org\/10.3390\/diagnostics13020221","journal-title":"Diagnostics (Basel)"},{"key":"934_CR98","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s11845-021-02759-0","volume":"191","author":"OH Aktepe","year":"2022","unstructured":"Aktepe, O. H., Gundogdu, F., Kosemehmetoglu, K., Yeter, H. H., Aksoy, S., Guven, D. C., Sahin, T. K., Yuce, D., Kertmen, N., Dizdar, O., Yalcin, S., & Erman, M. (2022). THSD7A expression: A novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy. Irish Journal of Medical Science, 191, 1561\u20131567. https:\/\/doi.org\/10.1007\/s11845-021-02759-0","journal-title":"Irish Journal of Medical Science"},{"key":"934_CR99","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3881\/j.issn.1000-503X.15212","volume":"45","author":"XL Tang","year":"2023","unstructured":"Tang, X. L., Du, Y. Y., Yu, J., Ye, T., Zhu, H., Chen, Y. F., & Li, X. H. (2023). Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 45, 235\u2013244. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.15212","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"934_CR100","doi-asserted-by":"publisher","first-page":"1002155","DOI":"10.3389\/fonc.2022.1002155","volume":"12","author":"Q Xu","year":"2022","unstructured":"Xu, Q., Zou, G., Zhuo, L., Gao, H., & Li, W. (2022). Lung cancer patients with nephropathy as the first manifestation: Literature review and clinical study report. Frontiers in Oncology, 12, 1002155. https:\/\/doi.org\/10.3389\/fonc.2022.1002155","journal-title":"Frontiers in Oncology"},{"key":"934_CR101","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fmed.2018.00101","volume":"5","author":"W Li","year":"2018","unstructured":"Li, W., Zhao, Y., & Fu, P. (2018). Diagnostic test accuracy of serum anti-PLA2R autoantibodies and glomerular PLA2R antigen for diagnosing idiopathic membranous nephropathy: An updated meta-analysis. Frontiers in Medicine, 5, 101. https:\/\/doi.org\/10.3389\/fmed.2018.00101","journal-title":"Frontiers in Medicine"},{"key":"934_CR102","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/asn.2018080852","volume":"30","author":"S Sethi","year":"2019","unstructured":"Sethi, S., Madden, B. J., Debiec, H., Charlesworth, M. C., Gross, L., Ravindran, A., Hummel, A. M., Specks, U., Fervenza, F. C., & Ronco, P. (2019). Exostosin 1\/Exostosin 2\u2013Associated Membranous Nephropathy. Journal of the American Society of Nephrology, 30, 1123\u20131136. https:\/\/doi.org\/10.1681\/asn.2018080852","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR103","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","volume":"97","author":"S Sethi","year":"2020","unstructured":"Sethi, S., Debiec, H., Madden, B., Charlesworth, M. C., Morelle, J., Gross, L., Ravindran, A., Buob, D., Jadoul, M., & Fervenza, F. C. (2020). Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney International, 97, 163\u2013174. https:\/\/doi.org\/10.1016\/j.kint.2019.09.014","journal-title":"Kidney International"},{"key":"934_CR104","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/mnh.0000000000000697","volume":"30","author":"P Ronco","year":"2021","unstructured":"Ronco, P., & Debiec, H. (2021). Membranous nephropathy: Current understanding of various causes in light of new target antigens. Current Opinion in Nephrology and Hypertension, 30, 287\u2013293. https:\/\/doi.org\/10.1097\/mnh.0000000000000697","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"934_CR105","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.kint.2020.05.030","volume":"98","author":"S Sethi","year":"2020","unstructured":"Sethi, S., Debiec, H., Madden, B., Vivarelli, M., Charlesworth, M. C., Ravindran, A., Gross, L., Ulinski, T., Buob, D., & Tran, C. L. (2020). Semaphorin 3B\u2013associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney international, 98, 1253\u20131264. https:\/\/doi.org\/10.1016\/j.kint.2020.05.030","journal-title":"Kidney international"},{"key":"934_CR106","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.kint.2020.09.016","volume":"100","author":"TN Caza","year":"2021","unstructured":"Caza, T. N., Hassen, S. I., Kuperman, M., Sharma, S. G., Dvanajscak, Z., Arthur, J., Edmondson, R., Storey, A., Herzog, C., & Kenan, D. J. (2021). Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney international, 100, 171\u2013181. https:\/\/doi.org\/10.1016\/j.kint.2020.09.016","journal-title":"Kidney international"},{"key":"934_CR107","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1681\/ASN.2020081165","volume":"32","author":"S Sethi","year":"2021","unstructured":"Sethi, S., Madden, B., Debiec, H., Morelle, J., Charlesworth, M. C., Gross, L., Negron, V., Buob, D., Chaudhry, S., & Jadoul, M. (2021). Protocadherin 7\u2013associated membranous nephropathy. Journal of the American Society of Nephrology: JASN, 32, 1249\u20131261. https:\/\/doi.org\/10.1681\/ASN.2020081165","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"934_CR108","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1681\/ASN.2020101395","volume":"32","author":"LF Al-Rabadi","year":"2021","unstructured":"Al-Rabadi, L. F., Caza, T., Trivin-Avillach, C., Rodan, A. R., Andeen, N., Hayashi, N., Williams, B., Revelo, M. P., Clayton, F., & Abraham, J. (2021). Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy. Journal of the American Society of Nephrology: JASN, 32, 1666\u20131681. https:\/\/doi.org\/10.1681\/ASN.2020101395","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"2","key":"934_CR109","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.34067\/kid.0001492021","volume":"360","author":"TN Caza","year":"2021","unstructured":"Caza, T. N., Hassen, S. I., Kenan, D. J., Storey, A., Arthur, J. M., Herzog, C., Edmondson, R. D., Bourne, T. D., Beck, L. H. J., & Larsen, C. P. (2021). Transforming Growth Factor Beta Receptor 3 (TGFBR3)\u2013Associated Membranous Nephropathy. Kidney, 360(2), 1275\u20131286. https:\/\/doi.org\/10.34067\/kid.0001492021","journal-title":"Kidney"},{"key":"934_CR110","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.kint.2021.08.014","volume":"100","author":"M Le Quintrec","year":"2021","unstructured":"Le Quintrec, M., Teisseyre, M., Bec, N., Delmont, E., Szwarc, I., Perrochia, H., Machet, M. C., Chauvin, A., Mavroudakis, N., & Taieb, G. (2021). Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy. Kidney International, 100, 1240\u20131249. https:\/\/doi.org\/10.1016\/j.kint.2021.08.014","journal-title":"Kidney International"},{"key":"934_CR111","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1681\/asn.2022050608","volume":"33","author":"L Reinhard","year":"2022","unstructured":"Reinhard, L., Machalitza, M., Wiech, T., Gr\u00f6ne, H.-J., Lass\u00e9, M., Rinschen, M. M., Ferru, N., Br\u00e4sen, J. H., Dr\u00f6mann, F., Rob, P. M., Sethi, S., Hoxha, E., & Stahl, R. A. K. (2022). Netrin G1 is a novel target antigen in primary membranous nephropathy. Journal of the American Society of Nephrology, 33, 1823\u20131831. https:\/\/doi.org\/10.1681\/asn.2022050608","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR112","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1681\/asn.2021111488","volume":"33","author":"S Sethi","year":"2022","unstructured":"Sethi, S., Madden, B., Casal Moura, M., Nasr, S. H., Klomjit, N., Gross, L., Negron, V., Charlesworth, M. C., Alexander, M. P., Leung, N., Specks, U., Fervenza, F. C., & Haas, M. (2022). Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1. Journal of the American Society of Nephrology, 33, 1033\u20131044. https:\/\/doi.org\/10.1681\/asn.2021111488","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR113","doi-asserted-by":"publisher","first-page":"693","DOI":"10.11817\/j.issn.1672-7347.2020.190109","volume":"45","author":"Z Gong","year":"2020","unstructured":"Gong, Z., Yuan, S., Zhu, X., Wang, Y., Yu, F., Yang, D., Xu, X., Liu, H., Li, J., & Sun, L. (2020). Clinical significance of M-type phospholipase A2 receptor and thrombospondin Type 1 domain-containing 7A in primary membranous nephropathy. Zhong Nan Da Xue Xue Bao. Yi Xue Ban, 45, 693\u2013700. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2020.190109","journal-title":"Zhong Nan Da Xue Xue Bao. Yi Xue Ban"},{"key":"934_CR114","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12882-021-02457-0","volume":"22","author":"A Matsumoto","year":"2021","unstructured":"Matsumoto, A., Matsui, I., Mano, K., Mizuno, H., Katsuma, Y., Yasuda, S., Shimada, K., Inoue, K., Oki, T., Hanai, T., Kojima, K., Kaneko, T., & Isaka, Y. (2021). Recurrent membranous nephropathy with a possible alteration in the etiology: A case report. BMC Nephrology, 22, 253. https:\/\/doi.org\/10.1186\/s12882-021-02457-0","journal-title":"BMC Nephrology"},{"key":"934_CR115","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.2169\/internalmedicine.6413-20","volume":"60","author":"S Watanabe","year":"2021","unstructured":"Watanabe, S., Suzuki, T., Han, W., Nakata, M., Koitabashi, K., Ichikawa, D., Kamijo-Ikemori, A., Koike, J., & Shibagaki, Y. (2021). Spontaneous remission of thrombospondin type-1 domain-containing-associated membranous nephropathy. Internal Medicine, 60, 3125\u20133128. https:\/\/doi.org\/10.2169\/internalmedicine.6413-20","journal-title":"Internal Medicine"},{"key":"934_CR116","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1681\/ASN.2016070776","volume":"28","author":"AS De Vriese","year":"2017","unstructured":"De Vriese, A. S., Glassock, R. J., Nath, K. A., Sethi, S., & Fervenza, F. C. (2017). A Proposal for a Serology-Based Approach to Membranous Nephropathy. Journal of the American Society of Nephrology, 28, 421\u2013430. https:\/\/doi.org\/10.1681\/ASN.2016070776","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefroe.2022.09.005","author":"E Sola-Porta","year":"2023","unstructured":"Sola-Porta, E., Buxeda, A., Lop, J., Naranjo-Hans, D., Gimeno, J., Lloveras-Rubio, B., Perez-Saez, M. J., Redondo-Pachon, D., & Crespo, M. (2023). THSD7A-positive membranous nephropathy after kidney transplantation: A case report. Nefrologia (Engl Ed). https:\/\/doi.org\/10.1016\/j.nefroe.2022.09.005","journal-title":"Nefrologia (Engl Ed)"},{"key":"934_CR118","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","volume":"68","author":"JM Francis","year":"2016","unstructured":"Francis, J. M., Beck, L. H., Jr., & Salant, D. J. (2016). Membranous nephropathy: A journey from bench to bedside. American Journal of Kidney Diseases, 68, 138\u2013147. https:\/\/doi.org\/10.1053\/j.ajkd.2016.01.030","journal-title":"American Journal of Kidney Diseases"},{"key":"934_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7040086","author":"SM Maifata","year":"2019","unstructured":"Maifata, S. M., Hod, R., Zakaria, F., & Abd Ghani, F. (2019). Primary membranous glomerulonephritis: The role of serum and urine biomarkers in patient management. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines7040086","journal-title":"Biomedicines"},{"key":"934_CR120","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.cir.92.8.2220","volume":"92","author":"SE Lipshultz","year":"1995","unstructured":"Lipshultz, S. E., Orav, E. J., Sanders, S. P., & Colan, S. D. (1995). Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circulation, 92, 2220\u20132225. https:\/\/doi.org\/10.1161\/01.cir.92.8.2220","journal-title":"Circulation"},{"key":"934_CR121","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jviromet.2017.06.017","volume":"248","author":"CM Tin","year":"2017","unstructured":"Tin, C. M., Yuan, L., Dexter, R. J., Parra, G. I., Bui, T., Green, K. Y., & Sosnovtsev, S. V. (2017). A Luciferase Immunoprecipitation System (LIPS) assay for profiling human norovirus antibodies. Journal of virological methods, 248, 116\u2013129. https:\/\/doi.org\/10.1016\/j.jviromet.2017.06.017","journal-title":"Journal of virological methods"},{"issue":"4","key":"934_CR122","doi-asserted-by":"publisher","first-page":"217","DOI":"10.34067\/kid.0005112022","volume":"360","author":"PD Burbelo","year":"2023","unstructured":"Burbelo, P. D., Olson, S. W., Keller, J. M., Joshi, M., Schwartz, D. M., Chuang, Y.-J., Lambeau, G., Beck, L. H. J., & Waldman, M. (2023). Prediagnostic appearance of thrombospondin type-1 domain 7A autoantibodies in membranous nephropathy. Kidney, 360(4), 217\u2013225. https:\/\/doi.org\/10.34067\/kid.0005112022","journal-title":"Kidney"},{"key":"934_CR123","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.3389\/fimmu.2018.03035","volume":"9","author":"F Von Haxthausen","year":"2018","unstructured":"Von Haxthausen, F., Reinhard, L., Pinnschmidt, H. O., Rink, M., Soave, A., Hoxha, E., & Stahl, R. A. (2018). Antigen-specific IgG subclasses in primary and malignancy-associated membranous nephropathy. Frontiers in immunology, 9, 3035. https:\/\/doi.org\/10.3389\/fimmu.2018.03035","journal-title":"Frontiers in immunology"},{"key":"934_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.593288","volume":"12","author":"V Tesar","year":"2021","unstructured":"Tesar, V., & Hruskova, Z. (2021). Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy. Frontiers in Immunology, 12, 593288. https:\/\/doi.org\/10.3389\/fimmu.2021.593288","journal-title":"Frontiers in Immunology"},{"key":"934_CR125","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1681\/asn.2016040449","volume":"28","author":"Dahan, K., Debiec, H., Plaisier, E., Cachanado, M., Rousseau, A., Wakselman, L., Michel, P.-A., Mihout, F., Dussol, B., Matignon, M., Mousson, C., Simon, T., Ronco, P., Group, o. b. o. t. G. S. and Group, t. G. S","year":"2017","unstructured":"Dahan, K., Debiec, H., Plaisier, E., Cachanado, M., Rousseau, A., Wakselman, L., Michel, P.-A., Mihout, F., Dussol, B., Matignon, M., Mousson, C., Simon, T., Ronco, P., Group, o. b. o. t. G. S. and Group, t. G. S. (2017). Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up. Journal of the American Society of Nephrology, 28, 348\u2013358. https:\/\/doi.org\/10.1681\/asn.2016040449","journal-title":"Journal of the American Society of Nephrology"},{"key":"934_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2022.103599","volume":"61","author":"P Tseke","year":"2022","unstructured":"Tseke, P., & Griveas, I. (2022). Immunoadsorption and covid 19 pandemic. Transfusion and Apheresis Science, 61, 103599. https:\/\/doi.org\/10.1016\/j.transci.2022.103599","journal-title":"Transfusion and Apheresis Science"},{"key":"934_CR127","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.ajkd.2019.05.021","volume":"74","author":"J Weinmann-Menke","year":"2019","unstructured":"Weinmann-Menke, J., Holtz, S., Sollinger, D., D\u00f6rken, M., Boedecker, S., Schamberger, B., Pfister, F., Amann, K., & Lutz, J. (2019). Treatment of membranous nephropathy in patients with THSD7A antibodies using immunoadsorption. American Journal of Kidney Diseases, 74, 849\u2013852. https:\/\/doi.org\/10.1053\/j.ajkd.2019.05.021","journal-title":"American Journal of Kidney Diseases"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00934-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00934-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00934-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T18:03:24Z","timestamp":1731089004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00934-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":127,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00934-5","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest related to this review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}